Decreased PARP and procaspase-2 protein levels are associated with cellular drug resistance in childhood acute lymphoblastic leukemia.
about
Caspase-2 as a tumour suppressorThe PIDDosome, DNA-damage-induced apoptosis and beyondAag DNA glycosylase promotes alkylation-induced tissue damage mediated by Parp1Old, new and emerging functions of caspases.Forced cytochrome B gene mutation expression induces mitochondrial proliferation and prevents apoptosis in human uroepithelial SV-HUC-1 cells.Acute lymphoblastic leukemia cells that survive combination chemotherapy in vivo remain sensitive to allogeneic immune effects.The tumor-modulatory effects of Caspase-2 and Pidd1 do not require the scaffold protein Raidd.Childhood acute lymphoblastic leukaemia and relapse.MiR-125a-5p decreases after long non-coding RNA HOTAIR knockdown to promote cancer cell apoptosis by releasing caspase 2Genetic deletion of caspase-2 accelerates MMTV/c-neu-driven mammary carcinogenesis in miceThe SWI/SNF chromatin-remodeling complex and glucocorticoid resistance in acute lymphoblastic leukemia.A tumor suppressor function for caspase-2The role of caspase-2 in stress-induced apoptosis.Impaired haematopoietic stem cell differentiation and enhanced skewing towards myeloid progenitors in aged caspase-2-deficient mice.Caspase-2: the orphan caspase.Cell death controlling complexes and their potential therapeutic role.Sensitization of cisplatin therapy by a naphthalimide based organoselenium compound through modulation of antioxidant enzymes and p53 mediated apoptosis.Caspase-2 is required for cell death induced by cytoskeletal disruption.Molecular Cell Biology of Apoptosis and Necroptosis in Cancer.Melittin induces NSCLC apoptosis via inhibition of miR-183
P2860
Q26863078-040B55B0-6315-4294-98CF-7363C4D578B4Q27003842-4869B15B-8C84-4428-9DB6-8A91E73F3C90Q27323759-7B3ACF00-C7EC-4817-B161-21838297115FQ27686885-8244DFFD-DE8C-4D6C-AD0C-B0E7033C4B84Q34334234-E1DCC264-79CF-4A83-92DC-1D4F0E04C8B4Q34634251-6830BFAE-E9BC-4ECF-AB82-0E23BC46057CQ36288329-4EB2D936-F80E-4C95-953F-634140BF6F7AQ36340652-B4492CA6-9D5E-4B9E-B294-E845687B4FAAQ36774965-46764119-F0F2-4A6F-8444-91CE11FA36C2Q37090126-A716613A-239F-46B4-A62E-4257E13FD37FQ37090821-58F91351-774E-4AD3-984A-E4DC0C66DC5AQ37146821-3DE75505-110A-4357-A912-D1A272A79569Q37310573-FF5A7D5A-237E-43B7-9068-61312AB550CDQ37603451-7799AB2E-73E7-45DA-ADA2-27BE2B02D8DFQ37954996-3D55635F-DC5F-47D2-8228-700FF523DC33Q38260863-C79FC79A-B32E-4099-9489-28227D15E998Q46765625-F5C1FA58-C597-4D05-98A2-D64DB2108B94Q46809696-AE349E6E-395C-4FE6-A490-441035863B78Q50221065-B268BCAF-F265-44D5-93A9-611DFF6CE305Q58806309-C6A8764E-0E84-4087-A3C2-36FAA4B85A29
P2860
Decreased PARP and procaspase-2 protein levels are associated with cellular drug resistance in childhood acute lymphoblastic leukemia.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh
2005年學術文章
@zh-hant
name
Decreased PARP and procaspase- ...... acute lymphoblastic leukemia.
@en
type
label
Decreased PARP and procaspase- ...... acute lymphoblastic leukemia.
@en
prefLabel
Decreased PARP and procaspase- ...... acute lymphoblastic leukemia.
@en
P2093
P1433
P1476
Decreased PARP and procaspase- ...... acute lymphoblastic leukemia.
@en
P2093
Amy Holleman
Anne R M von Bergh
Gritta E Janka-Schaub
H Berna Beverloo
Karin M Kazemier
P304
P356
10.1182/BLOOD-2004-11-4296
P407
P577
2005-05-17T00:00:00Z